Pierre Acklin

发表

New Methods for Ligand-Based Virtual Screening: Use of Data Fusion and Machine Learning to Enhance the Effectiveness of Similarity Searching

Jérôme Hert, Peter Willett, David J Wilton, 2006, J. Chem. Inf. Model..

Sequential Superparamagnetic Clustering for Unbiased Classification of High-Dimensional Chemical Data

Ruedi Stoop, Pierre Acklin, Edgar Jacoby, 2004, J. Chem. Inf. Model..

Comparison of Fingerprint-Based Methods for Virtual Screening Using Multiple Bioactive Reference Structures

Jérôme Hert, Peter Willett, Pierre Acklin, 2004, J. Chem. Inf. Model..

Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins

Pierre Acklin, Edgar Jacoby, Ansgar Schuffenhauer, 2003, J. Chem. Inf. Comput. Sci..

Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection.

Peter Meier, Pierre Acklin, Kamal Azzaoui, 2005, Current topics in medicinal chemistry.

Enrichment of Extremely Noisy High-Throughput Screening Data Using a Naïve Bayes Classifier

Meir Glick, Pierre Acklin, Anthony E. Klon, 2004, Journal of biomolecular screening.

New Scoring Functions for Virtual Screening from Molecular Dynamics Simulations with a Quantum-Refined Force-Field (QRFF-MD). Application to Cyclin-Dependent Kinase 2

Alessandro Curioni, Eric Vangrevelinghe, Tiziana Mordasini, 2006, J. Chem. Inf. Model..

New Scoring Functions for Virtual Screening from Molecular Dynamics Simulations with a Quantum‐Refined Force‐Field (QRFF‐MD). Application to Cyclin‐Dependent Kinase 2.

Alessandro Curioni, Eric Vangrevelinghe, Tiziana Mordasini, 2006 .

The Contribution of Molecular Informatics to Chemogenomics. Knowledge‐Based Discovery of Biological Targets and Chemical Lead Compounds

Pierre Acklin, Edgar Jacoby, Ansgar Schuffenhauer, 2005 .

Sequential Superparamagnetic Clustering for Unbiased Classification of High‐Dimensional Chemical Data.

Ruedi Stoop, Pierre Acklin, Edgar Jacoby, 2004 .

Molecular Informatics as an enabling in silico technology platform for drug discovery

Eric Vangrevelinghe, Pierre Acklin, Kamal Azzaoui, 2004 .